Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and January 2017

Showing 1 to 10 of 315
Title Reference number Published Last updated
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib Reference number:TA427 TA00427 Published:January 2017 20170101 Last updated:January 2017 20170111
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy Reference number:TA428 TA00428 Published:January 2017 20170101 Last updated:January 2017 20170111
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy Reference number:TA421 TA00421 Published:December 2016 20161201 Last updated:December 2016 20161221
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer Reference number:TA422 TA00422 Published:December 2016 20161201 Last updated:December 2016 20161221
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens Reference number:TA423 TA00423 Published:December 2016 20161201 Last updated:December 2016 20161221
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer Reference number:TA424 TA00424 Published:December 2016 20161201 Last updated:December 2016 20161221
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia Reference number:TA425 TA00425 Published:December 2016 20161201 Last updated:December 2016 20161221
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia Reference number:TA426 TA00426 Published:December 2016 20161201 Last updated:December 2016 20161221
Ticagrelor for preventing atherothrombotic events after myocardial infarction Reference number:TA420 TA00420 Published:December 2016 20161201 Last updated:December 2016 20161214
Nivolumab for previously treated advanced renal cell carcinoma Reference number:TA417 TA00417 Published:November 2016 20161101 Last updated:November 2016 20161123